Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study-Reference-Cited by-同舟云学术

Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study

Published:2011-03 Issue:9768 Volume:377 Page:813-822
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Fizazi Karim,Carducci Michael,Smith Matthew,Damião Ronaldo,Brown Janet,Karsh Lawrence,Milecki Piotr,Shore Neal,Rader Michael,Wang Huei,Jiang Qi,Tadros Sylvia,Dansey Roger,Goessl Carsten

Publisher

Elsevier BV

Subject

General Medicine

Reference33 articles.

1. Cancer statistics, 2010;Jemal;CA Cancer J Clin,2010

2. Estimates of cancer incidence and mortality in Europe in 2008;Ferlay;Eur J Cancer,2010

3. Economic burden of metastatic bone disease in the U.S.;Schulman;Cancer,2007

4. A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma;Saad;J Natl Cancer Inst,2002

5. Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer;Saad;J Natl Cancer Inst,2004

Cited by 1642 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Crosstalk between bone metastatic cancer cells and sensory nerves in bone metastatic progression;Life Science Alliance;2024-09-12

2. The use of denosumab in osteoporosis – an update on efficacy and drug safety;Expert Opinion on Drug Safety;2024-09-11

3. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II—2024 Update: Treatment of Relapsing and Metastatic Prostate Cancer;European Urology;2024-08

4. Increase in major osteoporotic fractures after therapy with immune checkpoint inhibitors;BMJ Oncology;2024-08

5. A multifaceted role of bisphosphonates from palliative care to anti-cancer therapy in solid tumors;Journal of Oncology Pharmacy Practice;2024-07-26